Core Viewpoint - Rithm (RITM) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Rising earnings estimates for Rithm suggest an improvement in the company's underlying business, likely leading to increased stock prices [5]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) to Zacks Rank 5 (Strong Sell), and has shown a strong track record of performance [7][9]. - Only the top 20% of Zacks-covered stocks receive a "Strong Buy" or "Buy" rating, indicating superior earnings estimate revisions [10]. Recent Earnings Estimate Revisions for Rithm - For the fiscal year ending December 2025, Rithm is expected to earn $2.15 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 1.6% over the past three months [8].

Core Viewpoint - W.P. Carey (WPC) has received a Zacks Rank 2 (Buy) upgrade due to an upward trend in earnings estimates, indicating a positive outlook for the company's stock price [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the importance of changing earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Rising earnings estimates for W.P. Carey suggest an improvement in the company's underlying business, likely leading to increased stock prices as investors respond positively [5][10]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - W.P. Carey’s upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [9][10]. Earnings Estimate Revisions for W.P. Carey - For the fiscal year ending December 2025, W.P. Carey is expected to earn $4.92 per share, with no year-over-year change, while the Zacks Consensus Estimate has increased by 0.9% over the past three months [8].

Company Overview - Rithm Capital Corp. (RITM) is a mortgage-focused real estate investment trust (REIT) with significant investments in the mortgage servicing rights (MSR) market, along with complementary investments in mortgage origination and servicing [1] Investment Focus - The REIT provides full dividend coverage, indicating a strong commitment to returning value to shareholders [1] Market Insights - The article highlights the growing interest in artificial intelligence (AI) and its transformative impact on various industries, suggesting that the coming decade will present remarkable investment opportunities [1]

Core Viewpoint - Agree Realty Corporation (ADC) is a strong real estate investment trust (REIT) with a solid financial foundation and consistent dividend payments, making it an attractive investment option for income-seeking investors [1][2][5]. Financial Performance - ADC's asset base exceeds $9 billion, showcasing its financial strength and stability [2][6]. - The company has a market capitalization of approximately $8.11 billion and a trading volume of 532,452 shares, indicating its significant presence in the REIT sector [5]. Stock Performance - As of November 25, 2025, ADC was priced at $75.19, with Wells Fargo maintaining an "Overweight" rating and increasing its price target from $81 to $83 [1][6]. - Currently, ADC is priced at $75.18, reflecting a 1.14% increase with a price change of $0.85, and has shown volatility over the past year with a high of $79.65 and a low of $67.58 [4]. Dividend and Preferred Stock - ADC has a 30-year history of consistent dividend payments, appealing to investors seeking reliable income [2][6]. - The preferred stock, ADC.PR.A, offers a yield of 5.88% and is rated BBB-/BBB/Baa2, making it an attractive option for conservative investors [3][6].

Core Points - A class action has been filed against Alexandria Real Estate Equities, Inc. (ARE) on behalf of investors who acquired its securities between January 27, 2025, and October 27, 2025 [1] - The allegations include misleading statements regarding Alexandria's financial prospects, particularly concerning revenue and funds from operations (FFO) growth for fiscal year 2025 [2] - On October 27, 2025, Alexandria reported disappointing third-quarter financial results and reduced its FFO guidance for the full year, citing lower occupancy rates and a significant real estate impairment charge of $323.9 million [3] Company Overview - Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT) focused on life science real estate, including lab space and research facilities for tenants in the pharmaceutical, biotech, and agricultural technology sectors [1] - The company has been promoting its Long Island City (LIC) property as a key part of its Megacampus™ strategy, which has come under scrutiny due to recent allegations [2] Financial Performance - The company experienced a significant decline in stock price, dropping approximately 19% from $77.87 per share on October 27, 2025, to $62.94 per share on October 28, 2025, following the announcement of its financial results [3]

Core Insights - NewLake Capital Partners, Inc. is participating in MJBizCon 2025, a major cannabis industry conference, from December 2–5, 2025, in Las Vegas [1][2] - The conference is the largest B2B cannabis event globally, attracting over 20,000 professionals and 1,000 exhibitors, serving as a key platform for networking and identifying trends in the cannabis economy [2] Company Overview - NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides capital to state-licensed cannabis operators through sale-leaseback transactions and funding for build-to-suit projects [3] - The company owns a portfolio of 34 properties, which includes 15 cultivation facilities and 19 dispensaries [3]

Core Insights - The article summarizes significant research calls from Wall Street, highlighting upgrades and downgrades of various companies that could impact investor decisions [1] Upgrades - Wolfe Research upgraded Inspire Medical (INSP) to Outperform from Peer Perform with a price target of $180, citing a "surprise" 50% Medicare reimbursement increase as a positive factor for the stock [2] - UBS upgraded Cummins (CMI) to Neutral from Sell with a price target of $500, increased from $350, indicating a balanced risk/reward as the truck cycle is expected to bottom in 2026 [2] - Raymond James upgraded CDW (CDW) to Strong Buy from Outperform with a price target of $185, noting that easing cost headwinds may lead to growth acceleration [3] - Citi upgraded Brinker (EAT) to Buy from Neutral with a price target of $176, up from $144, as the cost environment improves with reduced food tariffs in Brazil, potentially boosting sales through fiscal 2026 [3] - UBS upgraded Applied Materials (AMAT) to Buy from Neutral with a price target of $285, raised from $250, based on a more optimistic outlook for wafer fab equipment spending in 2026 and 2027 [4] Downgrades - Argus downgraded Coinbase (COIN) to Hold from Buy with no price target, citing the stock's high valuation at 39 times expected forward earnings compared to lower multiples of other exchanges [5] - Rothschild & Co Redburn downgraded Estee Lauder (EL) to Sell from Neutral with a price target of $70, down from $83, due to the need for deeper investment despite improving sales growth [5] - Canaccord downgraded Exact Sciences (EXAS) to Hold from Buy with a price target of $105, up from $85, following the announcement of an acquisition agreement by Abbott (ABT) at $105 per share [5] - Northland downgraded Green Dot (GDOT) to Market Perform from Outperform with a price target of $14.25, down from $18, after the announcement of complex strategic transactions separating its fintech and bank operations [5] - Barclays downgraded Camden Property (CPT) to Equal Weight from Overweight with a price target of $118, down from $127, as its total return profile is now seen as average compared to the apartment REIT sector [5]

Core Insights - The U.S. equity markets are currently experiencing volatility due to high valuations, sluggish economic signals, and uncertainty regarding the Federal Reserve's future actions, particularly affecting growth and AI-linked stocks [1] Group 1: Stock Selection Strategy - Retail investors face challenges in stock selection amidst market volatility, making traditional stock-picking methods more relevant [2] - Sales growth is emphasized as a more reliable metric for evaluating stocks compared to earnings growth, as it reflects underlying demand and business model durability [3][10] - Sustained sales growth leads to predictable cash flows, allowing companies to reinvest and maintain stability without excessive borrowing [5] Group 2: Screening Parameters for Stocks - Selected stocks should have a 5-Year Historical Sales Growth (%) greater than the industry average and Cash Flow exceeding $500 million [6] - Additional criteria include a Price-to-Sales (P/S) Ratio lower than the industry average, indicating better value for revenue [7] - Positive revisions in sales estimates compared to the industry can trigger stock price increases [7] Group 3: Key Metrics for Evaluation - An operating margin greater than 5% over the last five years indicates effective cost control and sales growth outpacing costs [8] - A Return on Equity (ROE) greater than 5% ensures that sales growth translates into profits, indicating wise spending and profitability [9] - Stocks with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) are expected to outperform in various market conditions [9] Group 4: Recommended Stocks - Take-Two Interactive (TTWO) is projected to have a sales growth rate of 14.8% for fiscal 2026 and holds a Zacks Rank of 1 [11] - Globus Medical (GMED) anticipates a sales growth rate of 14.5% for 2025, also with a Zacks Rank of 1 [12] - Rockwell Automation (ROK) expects a sales increase of 5.8% in fiscal 2026 and has a Zacks Rank of 2 [13] - Canadian Natural Resources (CNQ) forecasts a sales growth of 5.7% for 2025, currently holding a Zacks Rank of 1 [14] - VICI Properties anticipates a sales growth of 4.1% in 2025 and has a Zacks Rank of 2 [15]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...